Related Experiment Video
Updated: Jun 5, 2026
08:34
Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
Natriuretic peptides and atrial fibrillation
D Marsiliani1, F Buccelletti, A Carroccia
1Department of Emergency Medicine, Catholic University of the Sacred Heart, Rome, Italy. davide.marsiliani@edu.rm.unicatt.it
European Review for Medical and Pharmacological Sciences
|January 13, 2011
Summary
Natriuretic polypeptides (NPs) show promise in managing atrial fibrillation (AF). NT-ProBNP can help physicians select the best rhythm or rate control strategy for AF patients, improving treatment decisions.
Area of Science:
- Cardiology
- Biomarker Research
Background:
- Atrial fibrillation (AF) is a common arrhythmia linked to increased mortality and morbidity, including stroke and heart failure.
- Effective AF management requires balancing stroke risk reduction with quality of life, necessitating careful selection of rate or rhythm control strategies.
- Natriuretic polypeptides (NPs) are explored as potential tools for optimizing AF patient management.
Purpose of the Study:
- To review the role of natriuretic polypeptides (NPs) in the management of atrial fibrillation (AF).
- To assess the potential of NPs as predictive markers for treatment response in AF patients.
- To evaluate NPs as a resource for guiding rhythm control decisions in AF.
Main Methods:
- A literature search was conducted on PubMed using keywords 'natriuretic peptides' and 'atrial fibrillation'.
- Relevant abstracts were reviewed, and pertinent articles were fully evaluated by the authors.
- The review discusses NP biology, physiology, and applications in heart failure, with a specific focus on their role in AF.
Main Results:
- NP biology and physiology are described, with general applications in heart failure outlined.
- The role of NPs as predictors of cardioversion in AF is reviewed and discussed.
- NPs may serve as a valuable resource for predicting cardioversion success, especially when traditional markers like echocardiography are not readily available.
Conclusions:
- Biomarkers such as NPs hold potential for predicting treatment response beyond heart failure management.
- In AF management, NT-ProBNP emerges as a promising tool to assist physicians in choosing between rhythm or rate control strategies.
- NPs may offer a practical approach to personalize AF treatment decisions.
Related Concept Videos
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
01:29Heart Failure II: Pathophysiology
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
01:17Hormonal Regulation of Blood Pressure
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction while...
01:22Heart Failure Drugs: Diuretics
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...